$PRVL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Prevail Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Prevail Therapeutics Inc.. Get notifications about new insider transactions in Prevail Therapeutics Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Carson William H. | Director | Option Exercise | D | 11.11 | 34,000 | 377,740 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Dai Yong | Chief Technology Of ... | Option Exercise | D | 16.91 | 43,500 | 735,585 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Dai Yong | Chief Technology Of ... | Option Exercise | D | 10.26 | 126,567 | 1,298,577 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Dai Yong | Chief Technology Of ... | Option Exercise | D | 0.18 | 200,172 | 36,031 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | ORBIMED ADVISORS LLC | Director | Sell | U | 0.00 | 13,822,463 | 0 | 0 | 13.8 M to 0 (-100.00 %) |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Abeliovich Asa | President & CEO | Option Exercise | D | 16.91 | 250,000 | 4,227,500 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Abeliovich Asa | President & CEO | Option Exercise | D | 10.26 | 178,681 | 1,833,267 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Abeliovich Asa | President & CEO | Option Exercise | D | 0.18 | 1,329,219 | 239,259 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Abeliovich Asa | President & CEO | Sell | U | 0.00 | 2,385,756 | 0 | 0 | 2.4 M to 0 (-100.00 %) |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Adams Timothy M | Director | Option Exercise | D | 16.98 | 17,000 | 288,660 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Adams Timothy M | Director | Option Exercise | D | 10.26 | 32,400 | 332,424 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Minkow Emily | Chief Business Offi ... | Option Exercise | D | 16.91 | 54,000 | 913,140 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Minkow Emily | Chief Business Offi ... | Option Exercise | D | 10.26 | 108,854 | 1,116,842 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Minkow Emily | Chief Business Offi ... | Option Exercise | D | 0.18 | 104,895 | 18,881 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Minkow Emily | Chief Business Offi ... | Option Exercise | D | 0.18 | 149,000 | 26,820 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Minkow Emily | Chief Business Offi ... | Sell | U | 0.00 | 13,000 | 0 | 0 | 13 K to 0 (-100.00 %) |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | D | 16.98 | 17,000 | 288,660 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | D | 10.26 | 32,000 | 328,320 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | D | 2.81 | 133,447 | 374,986 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Sell | U | 0.00 | 23,747 | 0 | 0 | 23.7 K to 0 (-100.00 %) |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Schwartz Kira M. | General Counsel | Option Exercise | D | 16.68 | 100,000 | 1,668,000 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Sevigny Jeffrey | Chief Medical Offic ... | Option Exercise | D | 16.91 | 89,000 | 1,504,990 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Sevigny Jeffrey | Chief Medical Offic ... | Option Exercise | D | 10.26 | 122,439 | 1,256,224 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Sevigny Jeffrey | Chief Medical Offic ... | Option Exercise | D | 0.18 | 400,342 | 72,062 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Sheng Morgan | Director | Option Exercise | D | 16.98 | 17,000 | 288,660 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Sheng Morgan | Director | Option Exercise | D | 10.62 | 20,000 | 212,400 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nussbaum Ran | Director | Option Exercise | D | 16.98 | 17,000 | 288,660 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Nussbaum Ran | Director | Sell | U | 0.00 | 1,576,881 | 0 | 0 | 1.6 M to 0 (-100.00 %) |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Option Exercise | D | 16.98 | 17,000 | 288,660 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Sell | U | 0.00 | 13,822,463 | 0 | 0 | 13.8 M to 0 (-100.00 %) |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Option Exercise | D | 16.98 | 17,000 | 288,660 | 0 | |
| Jan 26 2021 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Sell | U | 0.00 | 13,822,463 | 0 | 0 | 13.8 M to 0 (-100.00 %) |
| Jan 22 2021 | PRVL | Prevail Therapeuti ... | Tyto Acquisition Corp | 10% Owner | Buy | P | 22.50 | 34,284,789 | 771,407,753 | 100 | -34,284,689 to 100 (-100.00 %) |
| Dec 31 2020 | PRVL | Prevail Therapeuti ... | Abeliovich Asa | President & CEO | Option Exercise | M | 10.26 | 120,537 | 1,236,710 | 178,681 | |
| Dec 31 2020 | PRVL | Prevail Therapeuti ... | Abeliovich Asa | President & CEO | Option Exercise | M | 0.18 | 5,256 | 946 | 1,329,219 | |
| Dec 31 2020 | PRVL | Prevail Therapeuti ... | Abeliovich Asa | President & CEO | Payment of Exercise | F | 23.02 | 89,037 | 2,049,632 | 2,385,756 | 2.5 M to 2.4 M (-3.60 %) |
| Dec 31 2020 | PRVL | Prevail Therapeuti ... | Abeliovich Asa | President & CEO | Buy | M | 10.26 | 120,537 | 1,236,710 | 2,474,793 | 2.4 M to 2.5 M (+5.12 %) |
| Dec 31 2020 | PRVL | Prevail Therapeuti ... | Abeliovich Asa | President & CEO | Buy | M | 0.18 | 5,256 | 946 | 2,354,256 | 2.3 M to 2.4 M (+0.22 %) |
| Sep 11 2020 | PRVL | Prevail Therapeuti ... | Carson William H. | Director | Option Exercise | A | 11.11 | 34,000 | 377,740 | 34,000 | |
| Jun 19 2020 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Option Exercise | A | 16.98 | 17,000 | 288,660 | 17,000 | |
| Jun 19 2020 | PRVL | Prevail Therapeuti ... | Sheng Morgan | Director | Option Exercise | A | 16.98 | 17,000 | 288,660 | 17,000 | |
| Jun 19 2020 | PRVL | Prevail Therapeuti ... | Nussbaum Ran | Director | Option Exercise | A | 16.98 | 17,000 | 288,660 | 17,000 | |
| Jun 19 2020 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Option Exercise | A | 16.98 | 17,000 | 288,660 | 17,000 | |
| Jun 19 2020 | PRVL | Prevail Therapeuti ... | Adams Timothy M | Director | Option Exercise | A | 16.98 | 17,000 | 288,660 | 17,000 | |
| Jun 19 2020 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | A | 16.98 | 17,000 | 288,660 | 17,000 | |
| Jun 03 2020 | PRVL | Prevail Therapeuti ... | Schwartz Kira M. | General Counsel | Option Exercise | A | 16.68 | 100,000 | 1,668,000 | 100,000 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Dai Yong | Chief Technology Of ... | Option Exercise | A | 16.91 | 43,500 | 735,585 | 43,500 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Hefti Franz | Chief Development O ... | Option Exercise | A | 16.91 | 62,200 | 1,051,802 | 62,200 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Hefti Franz | Chief Development O ... | Option Exercise | A | 16.91 | 62,200 | 1,051,802 | 62,200 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Minkow Emily | Chief Business Offi ... | Option Exercise | A | 16.91 | 54,000 | 913,140 | 54,000 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Minkow Emily | Chief Business Offi ... | Option Exercise | A | 16.91 | 54,000 | 913,140 | 54,000 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Kaplan Brett | Chief Financial Off ... | Option Exercise | A | 16.91 | 95,000 | 1,606,450 | 95,000 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Kaplan Brett | Chief Financial Off ... | Option Exercise | A | 16.91 | 95,000 | 1,606,450 | 95,000 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Abeliovich Asa | President & CEO | Option Exercise | A | 16.91 | 250,000 | 4,227,500 | 250,000 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Abeliovich Asa | President & CEO | Option Exercise | A | 16.91 | 250,000 | 4,227,500 | 250,000 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Sevigny Jeffrey | Chief Medical Offic ... | Option Exercise | A | 16.91 | 89,000 | 1,504,990 | 89,000 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Sevigny Jeffrey | Chief Medical Offic ... | Option Exercise | A | 16.91 | 89,000 | 1,504,990 | 89,000 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Minkow Emily | Chief Business Offi ... | Option Exercise | M | 0.18 | 13,000 | 2,340 | 149,000 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Minkow Emily | Chief Business Offi ... | Buy | M | 0.18 | 13,000 | 2,340 | 13,000 | 0 to 13 K |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Minkow Emily | Chief Business Offi ... | Option Exercise | M | 0.18 | 13,000 | 2,340 | 149,000 | |
| Mar 11 2020 | PRVL | Prevail Therapeuti ... | Minkow Emily | Chief Business Offi ... | Buy | M | 0.18 | 13,000 | 2,340 | 13,000 | 0 to 13 K |
| Nov 18 2019 | PRVL | Prevail Therapeuti ... | Sheng Morgan | Director | Option Exercise | A | 10.62 | 20,000 | 212,400 | 20,000 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 1,011,499 | 0 | 0 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 3,099,612 | 0 | 0 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Option Exercise | C | 0.00 | 6,399,000 | 0 | 0 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Buy | P | 17.00 | 882,352 | 14,999,984 | 13,822,463 | 12.9 M to 13.8 M (+6.82 %) |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | Thompson Peter A. | Director | Buy | C | 0.00 | 10,510,111 | 0 | 12,940,111 | 2.4 M to 12.9 M (+432.51 %) |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 1,011,499 | 0 | 0 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 3,099,612 | 0 | 0 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Option Exercise | C | 0.00 | 6,399,000 | 0 | 0 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Buy | P | 17.00 | 882,352 | 14,999,984 | 13,822,463 | 12.9 M to 13.8 M (+6.82 %) |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | GORDON CARL L | Director | Buy | C | 0.00 | 10,510,111 | 0 | 12,940,111 | 2.4 M to 12.9 M (+432.51 %) |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,011,499 | 0 | 0 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 3,099,612 | 0 | 0 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 6,399,000 | 0 | 0 | |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 882,352 | 14,999,984 | 13,822,463 | 12.9 M to 13.8 M (+6.82 %) |
| Jun 26 2019 | PRVL | Prevail Therapeuti ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 10,510,111 | 0 | 12,940,111 | 2.4 M to 12.9 M (+432.51 %) |
| Jun 25 2019 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Option Exercise | C | 0.00 | 23,747 | 0 | 0 | |
| Jun 25 2019 | PRVL | Prevail Therapeuti ... | Nader Francois | Director | Buy | C | 0.00 | 23,747 | 0 | 23,747 | 0 to 23.7 K |
Page: 1